FDA approves Neurocrine Biosciences' Huntington's disease drug-March 2024-www.financetom.com

FDA approves Neurocrine Biosciences' Huntington's disease drug

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

FDA approves Neurocrine Biosciences' Huntington's disease drug

Apr 30, 2024 3:02 PM

April 30 (Reuters) - The U.S. Food and Drug

Administration (FDA) has approved granule formulation of

Neurocrine Biosciences' ( NBIX ) drug to treat movement

disorders associated with Huntington's disease, the company said

on Tuesday.

Previous page： HUYA's Q4 Adjusted Loss Narrows, Revenue Decreases Next page： Golden Minerals Gains 5% In US Pre-Market Trading As Narrows Full-Year 2023 Net Loss YOY, Provides 2024 Financial Outlook

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

HUYA's Q4 Adjusted Loss Narrows, Revenue Decreases

Mar 19, 2024

07:11 AM EDT, 03/19/2024 (MT Newswires) -- HUYA ( HUYA ) reported a Q4 adjusted loss Tuesday of 0.79 renminbi ($0.11) per diluted American depositary share, narrowing from 1.81 renminbi a year earlier. Analysts' estimates were not available for comparison. Revenue for the quarter ended Dec. 31 was 1.53 billion renminbi, down from 2.12 billion renminbi a year earlier. Five...

Golden Minerals Gains 5% In US Pre-Market Trading As Narrows Full-Year 2023 Net Loss YOY, Provides 2024 Financial Outlook

Mar 19, 2024

07:11 AM EDT, 03/19/2024 (MT Newswires) -- Golden Minerals Co. ( AUMN ) on Tuesday reported full-year 2023 net loss of US$9.2 million, or US$1.08 per share, narrowing from US$9.9 million, or US$1.49 per share, a year ago. Total 2023 revenue came in at US$12.0 million, a decrease from US$23.3 million in 2022. Cash inflows during 2023 totaled US$9.7 million...

Pembina Pipeline gets regulatory approval to buy Enbridge's JV interests

Mar 19, 2024

March 19 (Reuters) - Pembina Pipeline ( PBA ) said on Tuesday the Canadian Competition Bureau has approved its proposed acquisition of Enbridge's ( ENB ) interests in the Alliance, Aux Sable, and NRGreen joint ventures. ...

IFF to Sell Pharma Solutions Unit to France's Roquette for Up to $2.85 Billion

Mar 19, 2024

07:15 AM EDT, 03/19/2024 (MT Newswires) -- International Flavors & Fragrances ( IFF ) said Tuesday it agreed to sell its Pharma Solutions unit to France's Roquette for an enterprise value of up to $2.85 billion. IFF and Roquette, a plant-based ingredients producer, expect to close the deal in H1 of next year, subject to customary closing conditions, including regulatory...